HAVENS ADVISORS LLC Buys 3, Sells 2 in 3rd Quarter

HAVENS ADVISORS LLC recently filed their 13F report for the third quarter of 2022, which ended on 2022-09-30.

The 13F report details which stocks were in a guru’s equity portfolio at the end of the quarter, though investors should note that these filings are limited in scope, containing only a snapshot of long positions in U.S.-listed stocks and American depository receipts as of the quarter’s end. They are not required to include international holdings, short positions or other types of investments. Still, even this limited filing can provide valuable information.

600 LEXINGTON AVE NEW YORK, NY 10022

As of the latest 13F report, the guru’s equity portfolio contained 41 stocks valued at a total of $66.00Mil. The top holdings were ROG(6.24%), CCXI(5.88%), and TMX(5.77%).

According to GuruFocus data, these were HAVENS ADVISORS LLC’s top five trades of the quarter.

Welbilt Inc


The guru sold out of their 187,000-share investment in NYSE:WBT. Previously, the stock had a 7.03% weight in the equity portfolio. Shares traded for an average price of $23.95 during the quarter.

On 10/12/2022, Welbilt Inc traded for a price of $24.01 per share and a market cap of $3.44Bil. The stock has returned 2.74% over the past year.

GuruFocus gives the company a financial strength rating of 4 out of 10 and a profitability rating of 7 out of 10.

In terms of valuation, Welbilt Inc has a price-earnings ratio of 60.56, a price-book ratio of 10.17, a EV-to-Ebitda ratio of 25.35 and a price-sales ratio of 2.52.

The price-to-GF Value ratio is 1.53, earning the stock a GF Value rank of 1.

ChemoCentryx Inc


The guru established a new position worth 75,000 shares in NAS:CCXI, giving the stock a 5.88% weight in the equity portfolio. Shares traded for an average price of $41.33 during the quarter.

On 10/12/2022, ChemoCentryx Inc traded for a price of $51.95 per share and a market cap of $3.73Bil. The stock has returned 44.31% over the past year.

GuruFocus gives the company a financial strength rating of 6 out of 10 and a profitability rating of 2 out of 10.

In terms of valuation, ChemoCentryx Inc has a price-book ratio of 15.67, a EV-to-Ebitda ratio of -27.49 and a price-sales ratio of 98.35.

The price-to-GF Value ratio is 1.11, earning the stock a GF Value rank of 3.

Alleghany Corp


The guru established a new position worth 4,400 shares in NYSE:Y, giving the stock a 5.61% weight in the equity portfolio. Shares traded for an average price of $838.84 during the quarter.

On 10/12/2022, Alleghany Corp traded for a price of $841.47 per share and a market cap of $11.33Bil. The stock has returned 30.40% over the past year.

GuruFocus gives the company a financial strength rating of 5 out of 10 and a profitability rating of 7 out of 10.

In terms of valuation, Alleghany Corp has a price-earnings ratio of 33.18, a price-book ratio of 1.43, a price-earnings-to-growth (PEG) ratio of 1.48, a EV-to-Ebitda ratio of 13.54 and a price-sales ratio of 0.98.

The price-to-GF Value ratio is 0.96, earning the stock a GF Value rank of 5.

Global Blood Therapeutics Inc


The guru established a new position worth 46,000 shares in NAS:GBT, giving the stock a 4.76% weight in the equity portfolio. Shares traded for an average price of $55.15 during the quarter.

On 10/12/2022, Global Blood Therapeutics Inc traded for a price of $68.49 per share and a market cap of $4.62Bil. The stock has returned 165.36% over the past year.

GuruFocus gives the company a financial strength rating of 4 out of 10 and a profitability rating of 1 out of 10.

In terms of valuation, Global Blood Therapeutics Inc has a price-book ratio of 38.94, a EV-to-Ebitda ratio of -16.54 and a price-sales ratio of 18.82.

The price-to-GF Value ratio is 0.85, earning the stock a GF Value rank of 6.

Vonage Holdings Corp


The guru sold out of their 160,000-share investment in NAS:VG. Previously, the stock had a 4.76% weight in the equity portfolio. Shares traded for an average price of $19.85 during the quarter.

On 10/12/2022, Vonage Holdings Corp traded for a price of $20.99 per share and a market cap of $5.39Bil. The stock has returned 48.13% over the past year.

GuruFocus gives the company a financial strength rating of 4 out of 10 and a profitability rating of 6 out of 10.

In terms of valuation, Vonage Holdings Corp has a price-book ratio of 9.36, a EV-to-Ebitda ratio of 79.11 and a price-sales ratio of 3.73.

The price-to-GF Value ratio is 1.34, earning the stock a GF Value rank of 1.


Please note, the numbers and facts quoted are as of the writing of this article and may not factor in the latest trading data or company announcements.

Want to provide feedback on this article? Have questions or concerns? Get in touch with us here, or email us at [email protected]!

This article is general in nature and does not represent the opinions of GuruFocus or any of its affiliates. This article is not intended to be financial advice, nor does it constitute investment advice or recommendations. It was written without regard to your individual situation or financial goals. We aim to bring you fundamental, data-driven analysis, The information on this site is in no way guaranteed for completeness, accuracy or in any other way.